Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Primary Hyperparathyroidism
NCT01558115Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Jan 2012
- Primary completion
- Oct 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in primary hyperparathyroidism (PHPT), sponsored by Columbia University. Started Jan 2012; status: terminated.
02
Drugs
denosumab
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT01558115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558115.